© Copyright 2025 American Medical Association. All rights reserved.
An on-body injector is a medical device designed to facilitate the automatic delivery of medication through subcutaneous injection at a scheduled time. This device is particularly beneficial for individuals who may have difficulty or choose not to self-administer traditional subcutaneous injections. By utilizing an on-body injector, patients can reduce the frequency of visits to healthcare providers for medication administration. The process begins with the selection of an appropriate site on the body, commonly the abdomen or the back of the arm, which is then prepared using an alcohol swab to ensure cleanliness and minimize the risk of infection. The injector is filled with the prescribed medication through a designated fill port, and the needle cover is removed to prepare for application. The adhesive backing of the injector is exposed by removing the plastic covering, allowing the injector to be affixed securely to the prepped skin area. Careful attention is given to ensure that the adhesive adheres well to the skin. The deployment of the plastic cannula is monitored through a viewing window on the injector, confirming that the needle has been properly retracted after insertion. Once set up, the device is programmed to deliver the medication subcutaneously at a predetermined time, ensuring that the patient receives their treatment as scheduled without the need for manual intervention.
© Copyright 2025 Coding Ahead. All rights reserved.
The application of an on-body injector is indicated for patients who require timed subcutaneous injections of medication but are unable or unwilling to perform self-administration. This device is particularly useful for individuals with conditions that necessitate regular medication delivery, allowing for improved adherence to treatment regimens while minimizing the need for frequent healthcare visits.
The procedure for applying an on-body injector involves several key steps to ensure proper placement and functionality of the device. First, the healthcare provider selects an appropriate site on the patient's body, typically the abdomen or the back of the arm, where the injector will be applied. This site is then thoroughly cleaned with an alcohol swab to reduce the risk of infection. Next, the medication is prepared by filling the injector through the designated fill port, ensuring that the correct dosage is loaded into the device.
After the application of the on-body injector, patients are typically monitored for any immediate reactions at the injection site. It is important to instruct patients on how to care for the site, including keeping it clean and dry. Patients should be informed about the expected timeline for medication delivery and advised to report any signs of irritation, infection, or device malfunction. Follow-up appointments may be scheduled to assess the effectiveness of the medication and the proper functioning of the injector, ensuring that the patient’s treatment plan remains on track.
| Short Descr | APPLICATON ON-BODY INJECTOR | Medium Descr | APPL ON-BODY INJECTOR FOR TIMED SUBQ INJECTION | Long Descr | Application of on-body injector (includes cannula insertion) for timed subcutaneous injection | Status Code | Active Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 5 - Incident To Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Berenson-Eggers TOS (BETOS) | D1G - Drugs Administered through DME | MUE | 1 |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter | 25 | Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59. | 58 | Staged or related procedure or service by the same physician or other qualified health care professional during the postoperative period: it may be necessary to indicate that the performance of a procedure or service during the postoperative period was: (a) planned or anticipated (staged); (b) more extensive than the original procedure; or (c) for therapy following a surgical procedure. this circumstance may be reported by adding modifier 58 to the staged or related procedure. note: for treatment of a problem that requires a return to the operating/procedure room (eg, unanticipated clinical condition), see modifier 78. | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. | CC | Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed) | CR | Catastrophe/disaster related | GC | This service has been performed in part by a resident under the direction of a teaching physician | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | JZ | Zero drug amount discarded/not administered to any patient | LT | Left side (used to identify procedures performed on the left side of the body) | PD | Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2017-01-01 | Added | Added |
Get instant expert-level medical coding assistance.